Remarkably, compared with children who never had bad dreams, those who had persistent bad dreams were 76% more likely to develop cognitive impairment and were 640% more likely to develop Parkinson’s.
Read More
BetterNight will use the proceeds from this growth funding transaction to continue its nationwide expansion through partnerships with physician practices, health systems, and insurers and to accelerate the adoption and growth of its value-based sleep solution to employers and health plans.
Read More
Royal Philips CEO Roy Jakobs provides updates on rebuilding Philips’ reputation around patient safety and quality, which he identifies in the company’s 2022 report as “our first priority.”
Read More
The prevalence of certain comorbidities is higher in people with narcolepsy compared with matched controls—both at diagnosis and at prolonged follow up.
Read More
The FDA updated its Philips Respironics recall safety communication this month to provide updated information about medical device reports received from November 1, 2022, to December 31, 2022.
Read More